hrcak mascot   Srce   HID

Ostalo

HEPATITIS C: WHO SHOULD BE TREATED?

DAVOR ŠTIMAC ; Rijeka University Hospital Center, Clinical Department of Medicine, Department of Gastroenterology, Rijeka, Croatia
NIKOLA BRADARIĆ ; Split University Hospital Center, Clinical Department of Infectious Diseases, Split, Croatia
SANDRA MILIĆ ; Rijeka University Hospital Center, Clinical Department of Medicine, Department of Gastroenterology, Rijeka, Croatia

Puni tekst: hrvatski, pdf (81 KB) str. 325-327 preuzimanja: 481* citiraj
APA 6th Edition
ŠTIMAC, D., BRADARIĆ, N. i MILIĆ, S. (2013). HEPATITIS C: KOGA LIJEČITI?. Acta medica Croatica, 67 (4), 325-327. Preuzeto s https://hrcak.srce.hr/113719
MLA 8th Edition
ŠTIMAC, DAVOR, et al. "HEPATITIS C: KOGA LIJEČITI?." Acta medica Croatica, vol. 67, br. 4, 2013, str. 325-327. https://hrcak.srce.hr/113719. Citirano 01.12.2020.
Chicago 17th Edition
ŠTIMAC, DAVOR, NIKOLA BRADARIĆ i SANDRA MILIĆ. "HEPATITIS C: KOGA LIJEČITI?." Acta medica Croatica 67, br. 4 (2013): 325-327. https://hrcak.srce.hr/113719
Harvard
ŠTIMAC, D., BRADARIĆ, N., i MILIĆ, S. (2013). 'HEPATITIS C: KOGA LIJEČITI?', Acta medica Croatica, 67(4), str. 325-327. Preuzeto s: https://hrcak.srce.hr/113719 (Datum pristupa: 01.12.2020.)
Vancouver
ŠTIMAC D, BRADARIĆ N, MILIĆ S. HEPATITIS C: KOGA LIJEČITI?. Acta medica Croatica [Internet]. 2013 [pristupljeno 01.12.2020.];67(4):325-327. Dostupno na: https://hrcak.srce.hr/113719
IEEE
D. ŠTIMAC, N. BRADARIĆ i S. MILIĆ, "HEPATITIS C: KOGA LIJEČITI?", Acta medica Croatica, vol.67, br. 4, str. 325-327, 2013. [Online]. Dostupno na: https://hrcak.srce.hr/113719. [Citirano: 01.12.2020.]

Sažetak
Therapy is strongly recommended in patients with acute infection, patients with elevated ALT levels, patients with normal ALT level and F ≥2 METAVIR score, in genotype 1 nonresponders and relapsers to antiviral therapy with triple therapy (pegylated interferon, ribavirin, bocaprevir or telaprevir), in patients with compensated cirrhosis and patients on hemodialysis. It is possible to treat patients with HBV and HIV co-infection, patients with severe HCV extrahepatic manifestations and patients with transplanted liver. Drug users and alcoholics can be treated after 6-month abstinence, but also with supportive therapy. This therapy is not recommended in patients with fulminant hepatitis, patients with persistent normal ALT levels and without fibrosis, in kidney transplant recipients and in pregnant women.

Ključne riječi
hepatitis C; treatment; patient selection

Hrčak ID: 113719

URI
https://hrcak.srce.hr/113719

[hrvatski]

Posjeta: 735 *